Table 1.
Baseline demographic, clinical and home characteristics
| Demographic | Mean ± SD or % of total |
|---|---|
| Age (years) | 42 ± 23 |
| Gender (female) | 65 |
| Race (Caucasian) | 98 |
| Cotinine (ng/mL serum) | 3.1 ± 2.6 |
| Clinical | |
| Duration of asthma (years) | 20 ± 13 |
| Atopic dermatitis (positive) | 15 |
| Allergic hay fever (positive) | 78 |
| Allergic eczema (positive) | 29 |
| Dose of inhaled corticosteroid (μg)a | 715 ± 412 |
| Home | |
| Age of home (years) | 43 ± 9.5 |
| With carpets (positive) | 85 |
| With cat (positive) | 13 |
| With dog (positive) | 17 |
a
Beclomethasone equivalent.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.